NO20040370L - Anvendelse av IL-18-inhibitorer i hypersensitivitetslidelser. - Google Patents

Anvendelse av IL-18-inhibitorer i hypersensitivitetslidelser.

Info

Publication number
NO20040370L
NO20040370L NO20040370A NO20040370A NO20040370L NO 20040370 L NO20040370 L NO 20040370L NO 20040370 A NO20040370 A NO 20040370A NO 20040370 A NO20040370 A NO 20040370A NO 20040370 L NO20040370 L NO 20040370L
Authority
NO
Norway
Prior art keywords
inhibitors
hypersensitivity disorders
hypersensitivity
disorders
Prior art date
Application number
NO20040370A
Other languages
English (en)
Other versions
NO335688B1 (no
Inventor
Yolande Chvatchko
Marie Kosco-Vilbois
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20040370L publication Critical patent/NO20040370L/no
Publication of NO335688B1 publication Critical patent/NO335688B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20040370A 2001-08-10 2004-01-27 Anvendelse av IL-18-inhibitorer i hypersensitivitetslidelser. NO335688B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01118811 2001-08-10
EP02100735 2002-06-20
PCT/EP2002/008591 WO2003013577A2 (en) 2001-08-10 2002-08-01 Use of il-18 inhibitors in hypersensitivity disorders

Publications (2)

Publication Number Publication Date
NO20040370L true NO20040370L (no) 2004-03-23
NO335688B1 NO335688B1 (no) 2015-01-19

Family

ID=26076673

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040370A NO335688B1 (no) 2001-08-10 2004-01-27 Anvendelse av IL-18-inhibitorer i hypersensitivitetslidelser.

Country Status (27)

Country Link
US (1) US20040247598A1 (no)
EP (1) EP1423138B1 (no)
JP (1) JP4301942B2 (no)
KR (1) KR20040030948A (no)
CN (1) CN100500210C (no)
AR (1) AR035274A1 (no)
AU (1) AU2002331376B2 (no)
BR (1) BRPI0211827B8 (no)
CA (1) CA2456247C (no)
CY (1) CY1116137T1 (no)
DK (1) DK1423138T3 (no)
EA (1) EA006745B1 (no)
ES (1) ES2533253T3 (no)
HK (1) HK1069780A1 (no)
HR (1) HRP20040071B1 (no)
HU (1) HU230377B1 (no)
IL (2) IL160230A0 (no)
ME (1) ME00547B (no)
MX (1) MXPA04001230A (no)
NO (1) NO335688B1 (no)
PL (1) PL227130B1 (no)
PT (1) PT1423138E (no)
RS (1) RS52224B (no)
SI (1) SI1423138T1 (no)
UA (1) UA78516C2 (no)
WO (1) WO2003013577A2 (no)
ZA (1) ZA200400442B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005258569B2 (en) * 2004-06-30 2012-05-03 Atsuo Sekiyama Indicator agent for noninflammatory stress response and use thereof
CA2609060C (en) 2005-06-03 2014-07-15 Urs Weber Production of recombinant il-18 binding protein
JP5091127B2 (ja) 2005-06-10 2012-12-05 アレス トレーディング ソシエテ アノニム Ｉｌ−１８結合タンパク質の精製のための方法
ES2514495T3 (es) 2006-05-25 2014-10-28 Glaxo Group Limited Anticuerpos humanizados modificados anti-interleucina-18
CN103458904B (zh) * 2010-12-16 2016-09-28 株式会社明治 格氏乳杆菌的菌体级分在制造用于减轻迟发型变态反应的组合物中的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US6087116A (en) * 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
DE69925581T2 (de) * 1998-03-09 2006-04-27 Vertex Pharmaceuticals Inc., Cambridge 1,2-diazepanderivate als inhibitoren des interleukin-1beta umwandelnden enzyms
CA2276216A1 (en) * 1998-06-24 1999-12-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo An artificial peptide capable of neutralizing the biological activity of interleukin-18
EP1110969A4 (en) * 1998-09-01 2002-01-09 Hayashibara Biochem Lab INTERLEUKIN 18 BINDING PROTEIN
WO2000071719A1 (en) * 1999-05-20 2000-11-30 Hyseq, Inc. Interleukin-1 hy2 materials and methods
AU2002224417A1 (en) * 2000-10-18 2002-04-29 Immunex Corporation Methods for treating il-18 mediated disorders

Also Published As

Publication number Publication date
PL368231A1 (en) 2005-03-21
SI1423138T1 (sl) 2015-04-30
HK1069780A1 (en) 2005-06-03
CN1568193A (zh) 2005-01-19
EP1423138A2 (en) 2004-06-02
BRPI0211827B8 (pt) 2021-05-25
HU230377B1 (hu) 2016-03-29
PL227130B1 (pl) 2017-10-31
MXPA04001230A (es) 2004-05-27
HRP20040071A2 (en) 2004-10-31
ME00547B (me) 2011-12-20
CA2456247A1 (en) 2003-02-20
HUP0401323A2 (hu) 2004-10-28
NO335688B1 (no) 2015-01-19
DK1423138T3 (en) 2015-02-23
AR035274A1 (es) 2004-05-05
EP1423138B1 (en) 2014-12-24
PT1423138E (pt) 2015-02-09
IL160230A (en) 2014-11-30
BR0211827A (pt) 2004-08-31
AU2002331376B2 (en) 2007-06-14
ZA200400442B (en) 2005-03-30
CY1116137T1 (el) 2017-02-08
HRP20040071B1 (hr) 2015-08-28
KR20040030948A (ko) 2004-04-09
EA006745B1 (ru) 2006-04-28
BRPI0211827B1 (pt) 2019-07-23
CN100500210C (zh) 2009-06-17
UA78516C2 (en) 2007-04-10
WO2003013577A3 (en) 2003-09-25
JP2005501080A (ja) 2005-01-13
US20040247598A1 (en) 2004-12-09
HUP0401323A3 (en) 2006-01-30
WO2003013577A2 (en) 2003-02-20
YU11904A (sh) 2006-08-17
CA2456247C (en) 2013-09-10
ES2533253T3 (es) 2015-04-08
EA200400296A1 (ru) 2004-06-24
IL160230A0 (en) 2004-07-25
RS52224B (sr) 2012-10-31
JP4301942B2 (ja) 2009-07-22

Similar Documents

Publication Publication Date Title
NL350092I2 (nl) Combinatie van bixafen en fluoxastrobine
NO20040097L (no) Kombinasjoner for behandling av inflammatoriske forstyrrelser
IS2529B (is) Nýjar spírótrísýklískar afleiður og notkun þeirra sem fosfódíesterasa-7-hindrar
IS8349A (is) 2,4-pýrimídíndíamín gagnleg í meðhöndlun æxlissjúkdóma, bólgu- og ónæmiskerfissjúkdóma
NO20044054L (no) Administrering av midler for behandling av betennelse
IS7700A (is) Ný spíróþétt kínasólínón og notkun þeirra sem fosfórdíesterasa hindrar
NO20041588L (no) Anvendelse av flibanserin ved behandling av seksuelle forstyrrelser
MXPA03006420A (es) Diaminotiazoles.
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
DE60319273D1 (de) Entzunderungsdüse
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
ATE512148T1 (de) Pyrazolo- und imidazopyrimidinderivate
ITMI20031311A0 (it) Formulazioni per il trattamento di disturbi artrosici
NO20043937L (no) Anvendelse av vitamin D sammensetninger
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
ATE440859T1 (de) Acylierte nonadepsipeptide vom lysobactin-typ
NO20034300L (no) Nye cyano-substituerte dihydropyrimidinforbindelser og anvendelse for behandling av sykdommer
NO20041968L (no) Anvendelse av cystationin
DE60326190D1 (de) des Körpers
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
HK1069780A1 (en) Use of il-18 inhibitors in hypersensitivity disorders
NO20041938L (no) Anvendelse av fosfodiesterase IV-inhibitorer
EE05263B1 (et) IL-18 inhibiitorite kasutamine keskn„rvissteemi kahjustuste raviks v?i ennetamiseks
FR2837224B1 (fr) Bonde traitante
ITMI20022358A1 (it) Composizioni farmaceutiche effervescenti per la realizzazione di sospensioni non convenzionali.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

MK1K Patent expired